ADRX Financials

Income Statement
MetricQ3 2026
Revenue
2.2M
Cost of Revenue
0
Gross Profit
2.2M
Operating Expenses
34.4M
R&D
26.7M
SG&A
7.7M
Operating Income
-32177000
EBITDA
-32177000
Net Income
-28117000
EPS (Basic)
$-1.74
EPS (Diluted)
$-1.74
Shares (Diluted)
16.1M
ADARx Pharmaceuticals (ADRX) — Financials